Thurday Feb 4, 2016 (foodconsumer.org) — Use of statins has actually been associated along with increased risk for type 2 diabetes mellitus in Asian people. Yet a brand-new study has actually now suggested that taking statins may help lower their risk for pancreatic cancer in those who have actually developed diabetes mellitus .
The study based on data from participants in the National Health Insurance Research database recorded from 1997–2010 in Taiwan found the rate of pancreatic cancer in diabetes mellitus patients who took statins in greater than 28 cumulative defined daily dose (cDDD) in a year were 0.14%, compared to 0.25% among those patients who used no statins or in much less than 28 cDDD per year.
Higher annual doses were associated along with lower risks for pancreatic cancer in diabetes mellitus patients. Specifically, after adjustment for other confounders, diabetics using statins in 28 to 83 cDDD per year, 84 to 180 cDDD per year or greater than 180 cDDD per year were 22%, 52% or 67% much less likely to develop pancreatic cancer, respectively. (David Liu)
Mei-Jyh Chen, Yu-Tse Tsan, Jyh-Ming Liou, Yi-Chia Lee, Ming-Shiang Wu, Han-Mo Chiu, Hsiu-Po Wang andPau-Chung Chen, Statins and the risk of pancreatic cancer in Type 2 diabetic patients—A population-based cohort study, Global Journal of Cancer, Volume 138, Issue 3, pages 594–603, 1 February 2016
(Send your news to foodconsumer.org@gmail.com, Foodconsumer.org is part of the Infoplus.com ™ news and information network)
